Gossamer Bio Is A Clinical Stage Biopharmaceutical Company Based In San Diegocaliforniafounded In 2015The Company Focuses On Developing Therapies For Rare Diseasesparticularly Pulmonary Hypertension Disordersgossamer Bio Is Known For Its Lead Productseralutinibgb002 An Inhaled Small Molecule Inhibitor Designed To Target Specific Receptors Involved In Vascular Remodeling And Inflammationthis Therapy Is Currently In Phase 3 Clinical Trials For Pulmonary Arterial Hypertensionpahand Pulmonary Hypertension Associated With Interstitial Lung Diseaseph Ildthe Company Operates Through Subsidiaries And Emphasizes Clinical Trial Optimizationmanaging Over 17 Clinical Trialsgossamer Bio Collaborates With Partners Like Pulmokineincto Advance The Development Of Seralutinib And Related Compoundswith A Strategic Focus On Rare Disease Marketsgossamer Bio Aims To Position Itself As A Future Commercial Stage Entity Dedicated To Improving Outcomes For Patients With Pulmonary Hypertension
